Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Pozycja w akcjach #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Cena akcji
$0.00060315
Ostatnia synchronizacja: 2024-09-27
Kapitalizacja rynkowa
$1.65M
Zmiana (1 dzień)
19.64%
Zmiana (1 rok)
0.00%
Kraj
SE
Handel Amniotics AB (publ) (AMNI)

Kategoria

Wskaźnik P/B dla Amniotics AB (publ) (AMNI)
Wskaźnik P/B na dzień August 2026 TTM: 0.98
Według najnowszych raportów finansowych i ceny akcji Amniotics AB (publ), obecny wskaźnik P/B (TTM) wynosi 0.98. Na koniec 2022 wynosił 43.73.
Historia wskaźnika P/B dla Amniotics AB (publ) od 2018 do 2026
Wskaźnik P/B na koniec każdego roku
Rok Wskaźnik P/B Zmień
2026 (TTM) 0.98 -40.17%
2023 1.63 -96.28%
2022 43.73 263.99%
2021 12.01 -34.02%
2020 18.21 -69.40%
2019 59.51 -75.80%
2018 245.87 0.00%
Wskaźnik P/B dla podobnych firm lub konkurentów
Firma Wskaźnik P/B Różnica wskaźnika P/B Kraj
6.3419 550.32%
US
6.2413 540.00%
NL
- -
CH
- -
KR
3.4612 254.92%
BE